Author: Alexandra Leonards

Bringing new drugs to market is a very expensive business: typically it can cost over €500 million and – given time limitations on patents – the pharmaceuticals company then has just 5-10 years or so to recoup its investment and make a profit for most the

It”s fair to say that, until now, most companies in the pharmaceutical and medical fields have had other things on their mind than maximising the efficiency of their supply chains. But what was once regarded as a minor cost component is coming under incr

No one ever got fired for having too much inventory, but they certainly have for running out of stock. With that warning from Professor David Simchi-Levi, of the Massachusetts Institute of Technology, ringing in their ears attendees at Supply Chain Standa